Increased treatment-related toxicity subsequent to an anti–PD-1 agent

類似資料

• The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma
  著者:: Khoja, Leila, 等
  出版事項: (2016)
• Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma
  著者:: KHOJA, LEILA, 等
  出版事項: (2016)
• Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients
  著者:: Khoja, Leila, 等
  出版事項: (2016)
• Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
  著者:: Naidoo, J., 等
  出版事項: (2016)
• Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
  著者:: Naidoo, J., 等
  出版事項: (2015)